02.03.2020
Julia Ritterhoff, University of Washington
Taking sugar and fat to heart - How metabolic rewiring drives cardiac growth
Place: Analysezentrum 3, INF 669, 2. Floor, Seminarroom 02.332
Time: 12 pm
28.02.2020
Niels Voigt, University Medical Center Göttingen
Atrial Cardiomyopathies: Many "molecular roads" lead to atrial fibrillation
Place: Analysezentrum 3, INF 669, 2. Floor, Seminarroom 02.332
Time: 12 pm
13.12. 2019
Michael S. Kapiloff, University of Stanford, Stanford
Signalosomes – Nodal Regulators and Therapeutic Targets For
Heart Failure
Place: Analysezentrum 3, INF 669, 2. Floor, Seminarroom 02.332
Time: 12 pm
04.11.2019
Joan Heller Brown, Univesity of California, San Diego
29.10.2019
Ulrich Kintscher, Charité Berlin, Germany
Place: Analysezentrum 3, INF 669, 2. Floor, Seminarroom 02.332
Time: 12 pm
16.07.2019
Alessandro Bertero, University of Washington, Seattle, USA
Functional dynamics of chromatin topology in human cardiogenesis and disease
07.06.2019
Jonathan Lambert, Temple University Philadelphia, USA
MCUB regulates the molecular composition of the mitochondrial calcium uniporter channel to limit mitochondrial calcium overload during cardiac stress
08.05.2019
Boris V. Skryabin, University Hospital Münster, Germany
Mouse genome engineering using the CRISPR/cas9 system
11.04.2019
Fabrice Chaumard, MR Solutions, Guildford, UK
Preclinical PET/MR imaging with cryogen-free superconducting MRI up to 9.4T
02.04.2019
Bert Klebl, Lead Discovery Center Dortmund, Germany
Connecting Academia and Venture Capital and/or Pharmaceutical Industry
12.03.2019
Jan Dudek, University Hospital Würzburg, Germany
Defective mitochondrial cardiolipin remodeling affects cardiac metabolism and cellular signaling
19.02.2019
Gabriele G. Schiattarella, UT Southwestern, Dallas, USA
Nitrosative Stress-dependent Suppression of Xbp1s Drives Heart Failure with Preserved Ejection Fraction
15.01.2019
Maria-Teresa Piccoli, Nature Communications
How to get published in Nature and its sister journals
12.12.2018
Robert Passier, University of Leiden, Netherlands
Human pluripotent stem cells derived cardiac cells for disease modelling and regenerative medicine - Towards heart-on-chip and 3D heart models
25.10.2018
Anja Karlstaedt, University of Texas, Houston, USA
Cancer and the heart - Oncometabolic dysregulation of cardiac metabolism
16.10.2018
Federica Accornero, Ohio State University, Ohio, USA
mRNA methylation and processing in cardiac remodeling
12.07.2018
Rushita Bagchi, University of Colorado, Denver, USA
Epigenetic Regulators: Turning Up the Heat on Metabolic Disease
19.04.2018
Donald M. Bers, University of California, Davis, USA
Cardiac Calcium and Calmodulin signaling in Arrhythmias and Heart Failure
16.02.2018
Björn Knollmann, Vanderbilt University, Nashville, USA
Mechanism and treatment of calcium triggered atrial and ventricular arrhythmia
22.01.2018
Ferdinand le Noble, KIT Karlsruhe, Germany
Therapeutic targeting of vascular development
09.06.2017
Yibin Wang, University of California, Los Angeles, USA
RNAs and Amino Acids: Novel Players and Therapeutic Targets for Heart Failure
06.03.2017
Saptarsi Haldar, Gladstone Institutes San Francisco, USA
Novel chromatin targets in heart failure
15.02.2017
Maarten van den Hoogenhof, AMC Amsterdam, Netherlands
RNA splicing in the heart - Changing parts and performance
07.12.2016
Manfred Jung, University of Freiburg, Germany
Epigenetic drug discovery - probing the bookmarks in the book of life
07.09.2016
Nazha Hamdani, Ruhr University Bochum, Germany
The road to understanding titin phosphorylation/oxidation and collagen in heart failure
with preserved ejection fraction
06.07.2016
Ajay Shah, King's College London, UK
Tuning cardiac stress responses: A surprising Nox story
01.06.2016
Dobromir Dobrev, University Hospital Essen, Germany
29.03.2016
Timothy A. McKinsey, University of Colorado, Denver